Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents

Irfana Muqbil1, Ashiq Masood, Fazlul H Sarkar

  • 1Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, UP, India. azmia@karmanos.org.

Cancers
|November 12, 2013
PubMed

Insights

Natural compounds show promise for cancer chemoprevention, but poor bioavailability limits clinical success. Nanotechnology enhances delivery, improving potential cancer treatments.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Natural dietary compounds like flavonoids and polyphenols exhibit anticancer properties in laboratory studies.
  • Clinical efficacy of these agents is often limited by poor systemic delivery and bioavailability.
  • Nanotechnology offers a promising solution to enhance the delivery and effectiveness of chemopreventive agents.

Purpose of the Study:

  • To review the advancements in nanochemoprevention technology.
  • To summarize current research on nano-encapsulated dietary anticancer agents.
  • To discuss the clinical applications and future directions of nanochemoprevention.

Main Methods:

  • Review of recent scientific literature on nanochemoprevention.
  • Analysis of studies on nano-encapsulated natural dietary compounds.
  • Synthesis of data on bioavailability and clinical outcomes.

Main Results:

  • Nanochemoprevention significantly enhances the bioavailability of natural anticancer agents.
  • Nano-encapsulation overcomes delivery barriers, improving therapeutic potential.
  • Numerous nano-formulations of dietary compounds have been developed.

Conclusions:

  • Nanochemoprevention represents a significant advancement in cancer chemoprevention.
  • Further development is expected to yield superior nanochemopreventive agents for clinical use.
  • This field holds promise for developing new standard cancer treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
111
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K